Industry Verticals »

All Categories

Insights »

About TMR »

Heparin Market

Heparin Market (Product - Unfractionated Heparin (UFH), Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH); Source - Bovine and Porcine; Formulation - Oral and Parenteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019- 2027

Global Heparin Market to Ride on the Back of High Prevalence of Cardiovascular Diseases

The rising number of surgeries and injuries is projected to be a major cause in the expansion of the global heparin market in the years to come. In addition to that, the rising prevalence of cardiovascular diseases and venous thromboembolism is projected to drive the demand for heparin in near future. Few biopharmaceutical firms are putting money into new drug development and manufacturing. Organizations such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are working to raise awareness via efforts aimed at reducing thrombosis-related complications in the early stages.

The global heparin market is projected to benefit from augmented demand for anticoagulants. In addition to that, high healthcare costs and low patient recognition are two major reasons expected to propel the industry forward in the coming years.

Increasing Use in Treating a Wide Variety of Illnesses to Boost Demand in the Market

Heparin is a drug that is utilized to cure or avoid a wide variety of lung, heart, and blood vessel, heart diseases. It's also utilized in the prevention of disorders pertaining to blood clotting, prophylaxis blood screening, and blood transfusions. Disseminated intravascular coagulation is a severe blood disease that can be diagnosed and treated with heparin. To avoid birth loss and other complications, heparin is often used alone or in conjunction with aspirin. Such extensive use of the drug is likely to support growth of the global heparin market

In addition to that, a spike in the number of surgical procedures and the high prevalence of illnesses such as coronary heart disease and deep vein thrombosis are likely to accentuate demand for heparin, resulting in market development. As per a 2018 report by American Heart Association, coronary heart disorder causes fatalities over 366,800 people in the US each year, accounting for one in every seven deaths. According to the same article, the total incidence of myocardial infarction (MI) in the US is about 7.9 million, or 3% of adult Americans.

The restraints of the global heparin market comprise the side effects associated with the consumption of heparin. Bleeding is heparin's most known side effect. the mouth and gums, uterus, ovaries, intestines, o pen wounds or surgical sites are all locations where heparin can cause accidental bleeding.

  • According to Transparency Market Research’s latest report on the global heparin market for the historical period 2017–2018 and forecast period 2019–2027, high incidence and mortality associated with coagulation disorders, commercialization of safe and cost-effective heparin products are projected to drive the global heparin market during the forecast period
  • According to the report, the global heparin market was valued at US$ 10.8 Bn in 2018 and is anticipated to expand at a CAGR of 6.8% from 2019 to 2027

High incidence and mortality associated with coagulation disorders and commercialization of safe and cost-effective heparin products: Key Drivers

  • Coagulation disorders such as venous thromboembolism (VTE) cause nearly half a Mn deaths in Europe each year. Astonishingly, the number of deaths due to VTE in Europe is more than the deaths collectively caused by AIDS, breast and prostate cancers, and highway accidents. According to the Centers for Disease Control and Prevention (CDC), the annual incidence of VTE (DVT & PE) in general population is estimated to be around 0.1%. Moreover, it states that approximately 900,000 people are affected by DVT/PE in the U.S. every year and one third of the DVT/PE patients have a recurrence within a decade.
  • A report published by Bayer HealthCare in 2013 stated that the incidence of VTE is expected to increase by 8% by 2018. These statistics clearly indicate the rising demand for safe, reliable, and affordable anticoagulants which would act as a growth driver for the heparin market. The prevailing limitation in reversing the activity of naturally-derived low molecular weight heparin (LMWH) in case of overdose could lead to excessive bleeding and harm to patients with poor kidney function. In 2014, researchers at the Rensselaer Polytechnic Institute and the University of North Carolina (UNC) developed a synthetic form of LMWH that is safe and can be reversed in activity using an antidote called protamine. According to the research, this synthetic heparin is safer and cheaper than the currently available heparin which is derived from animals. Regulatory approval would generate even higher demand for this synthetic version while affecting the existing demand for naturally derived heparin.

Rising Geriatric Population is Affected More by Thrombosis Boost Market Growth

  • Venous thromboembolism (VTE) is highly common in the geriatric population; however, it can occur at any age. The incidence rate of various disease such as heart failure, which can lead to thrombosis and is likely to occur more in old age than compare to young age
  • Congestive heart failure is much more frequent in elderly people, with 85% of patients with heart failure being older than 65 years. The prevalence of atrial fibrillation increases three times in people aged 80 years and above, as compared to those aged less than 65 years. Such incidences increase the risk of pulmonary embolism, more in the geriatric population, as the geriatric population with heart failure have limited heart and lung function, and the symptoms caused by even a small pulmonary embolism are more noticeable.
  • Hence, rising geriatric population is expected to drive the market for heparin drugs during the forecast period

Presence of alternative anticoagulants impeding the sale of biological heparin products to Hamper Market

  • Presence of alternative anticoagulants such as warfarin, oral anticoagulants, and coumarins is restraining the market for heparin used in the treatment of embolism.
  • Warfarin has traditionally been the key preferred drug for anticoagulant therapy globally. Moreover, the advent of new anticoagulants such as rivaroxaban, dabigatran, and apixaban is cannibalizing the market share of heparin globally.
  • Heparin is derived from animal sources; hence, the risk of infection and contamination always exists. Although these substitutes also possess certain limitations in terms of side effects and drug interactions, a physician can prefer these drugs over heparin depending on the condition of the patient and the type of disorder.

Global Heparin Market: Competitive Landscape

  • This report profiles major players in the global heparin market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global heparin market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global heparin market are
    • Dr. Reddy’s Laboratories Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Fresenius SE & Co. KGaA
    • Sanofi
    • Pfizer, Inc.
    • LEO Pharma A/S
    • Aspen
    • Baxter International Inc.,
    • B. Braun Melsungen AG
    • Syntex S.A. among others

Global Heparin Market: Key Developments

Key players in the global heparin market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global heparin market. A few expansion strategies adopted by players operating in the global heparin market are:

  • In September 2019, Meitheal Pharmaceuticals announced the launch of heparin sodium injection, USP in the United States (US).
  • In April 2019, B. Braun Medical Inc. launched Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the United States.
  • In December 2017, Mylan received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Heparin Sodium Injection USP, 1,000 USP/mL, 5,000 USP/mL, 10,000 USP/mL, and 20,000 USP/mL, all of which are packaged in multi-dose vials.

The report on the global heparin market discussed individual strategies, followed by company profiles of manufacturers of heparin. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global heparin market.

Frequently Asked Questions

What is the total market worth of heparin market?

Heparin market to gain a valuation of US$ 19.4 Bn by 2027

What is the anticipated CAGR of the heparin market in the forecast period?

Heparin market is estimated to reach a CAGR of 6.8% from 2019 to 2027

What are the key driving factors for the growth of the heparin market?

Heparin market is driven by rising geriatric population and rising prevalence of cardiovascular diseases and venous thromboembolism

Which region is expected to project the highest market share in the global heparin market?

North America accounted for a major share of the global heparin market

Who are the key players in the global heparin market?

Key players in the heparin market include Syntex S.A., B. Braun Melsungen AG, Baxter International Inc., Aspen, LEO Pharma A/S, Pfizer, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Heparin Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Heparin Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Market Strategies adopted by Top Players

    5.2. Snapshot – Brand Analysis

    5.3. Porter’s Five Forces Analysis

6. Global Heparin Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Heparin Market Value Forecast, by Product, 2017–2027

        6.2.1. Low Molecular Weight Heparin (LMWH)

        6.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

        6.2.3. Unfractionated Heparin (UFH)

    6.3. Global Heparin Market Attractiveness, by Product

7. Global Heparin Market Analysis and Forecast, by Source

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Heparin Market Value Forecast, by Source, 2017–2027

        7.2.1. Bovine

        7.2.2. Porcine

    7.3. Global Heparin Market Attractiveness, by Source

8. Global Heparin Market Analysis and Forecast, by Formulation

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Heparin Market Value Forecast, by Formulation, 2017–2027

        8.2.1. Oral

        8.2.2. Parenteral

    8.3. Global Heparin Market Attractiveness, by Formulation

9. Global Heparin Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Heparin Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. North America Heparin Market Attractiveness, by Region

10. North America Heparin Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

        10.2.1. Low Molecular Weight Heparin (LMWH)

        10.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

        10.2.3. Unfractionated Heparin (UFH)

    10.3. North America Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

        10.3.1. Bovine

        10.3.2. Porcine

    10.4. North America Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

        10.4.1. Oral

        10.4.2. Parenteral

    10.5. North America Heparin Market Value (US$ Mn) Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Heparin Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Source

        10.6.3. By Formulation

        10.6.4. By Country

11. Europe Heparin Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

        11.2.1. Low Molecular Weight Heparin (LMWH)

        11.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

        11.2.3. Unfractionated Heparin (UFH)

    11.3. Europe Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

        11.3.1. Bovine

        11.3.2. Porcine

    11.4. Europe Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

        11.4.1. Oral

        11.4.2. Parenteral

    11.5. Europe Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Heparin Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Source

        11.6.3. By Formulation

        11.6.4. By Country/Sub-region

12. Asia Pacific Heparin Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

        12.2.1. Low Molecular Weight Heparin (LMWH)

        12.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

        12.2.3. Unfractionated Heparin (UFH)

    12.3. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

        12.3.1. Bovine

        12.3.2. Porcine

    12.4. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

        12.4.1. Oral

        12.4.2. Parenteral

    12.5. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Heparin Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Source

        12.6.3. By Formulation

        12.6.4. By Country/Sub-region

13. Latin America Heparin Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

        13.2.1. Low Molecular Weight Heparin (LMWH)

        13.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

        13.2.3. Unfractionated Heparin (UFH)

    13.3. Latin America Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

        13.3.1. Bovine

        13.3.2. Porcine

    13.4. Latin America Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

        13.4.1. Oral

        13.4.2. Parenteral

    13.5. Latin America Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America Latin America

    13.6. Latin America Heparin Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Source

        13.6.3. By Formulation

        13.6.4. By Country/Sub-region

14. Middle East & Africa Heparin Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

        14.2.1. Low Molecular Weight Heparin (LMWH)

        14.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

        14.2.3. Unfractionated Heparin (UFH)

    14.3. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

        14.3.1. Bovine

        14.3.2. Porcine

    14.4. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

        14.4.1. Oral

        14.4.2. Parenteral

    14.5. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Heparin Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Source

        14.6.3. By Formulation

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by Tier and Size of companies)

    15.2. Market Share / Position Analysis, by Company, 2018

    15.3. Competitive Business Strategies

    15.4. Company Profiles

        15.4.1. Dr. Reddy’s Laboratories Ltd

            15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.1.2. Growth Strategies

            15.4.1.3. SWOT Analysis

        15.4.2. Teva Pharmaceutical Industries Ltd

            15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.2.2. Growth Strategies

            15.4.2.3. SWOT Analysis

        15.4.3. Fresenius SE & Co. KGaA

            15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.3.2. Growth Strategies

            15.4.3.3. SWOT Analysis

        15.4.4. Sanofi

            15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.4.2. Growth Strategies

            15.4.4.3. SWOT Analysis

        15.4.5. Pfizer, Inc.

            15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.5.2. Growth Strategies

            15.4.5.3. SWOT Analysis

        15.4.6. LEO Pharma A/S

            15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.6.2. Growth Strategies

            15.4.6.3. SWOT Analysis

        15.4.7. Aspen

            15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.7.2. Growth Strategies

            15.4.7.3. SWOT Analysis

        15.4.8. Baxter International Inc.

            15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.8.2. Growth Strategies

            15.4.8.3. SWOT Analysis

        15.4.9. B. Braun Melsungen AG

            15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.9.2. Growth Strategies

            15.4.9.3. SWOT Analysis

        15.4.10. Syntex S.A

            15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.4.10.2. Growth Strategies

            15.4.10.3. SWOT Analysis

List of Table

Table 1: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 2: Global Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 3: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

Table 4: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Region, 2018-2027

Table 5: North America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 6: North America Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 7: North America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

Table 8: North America Heparin Market Value (US$ Mn) Forecast, by Country, 2018-2027

Table 9: U.S. Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 10: U.S. Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 11: Canada Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 12: Canada Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 13: Europe Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 14: Europe Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 15: Europe Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

Table 16: Europe Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2027

Table 17: Germany Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 18: Germany Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 19: U.K. Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 20: U.K. Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 21: France Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 22: France Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 23: Italy Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 24: Italy Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 25: Spain Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 26: Spain Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 27: Rest of Europe Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 28: Rest of Europe Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 29: Asia Pacific Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 30: Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 31: Asia Pacific Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

Table 32: Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Country, 2018-2027

Table 33: China Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 34: China Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 35: India Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 36: India Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 37: Japan Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 38: Japan Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 39: Australia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 40: Australia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 41: Indonesia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 42: Indonesia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 43: Malaysia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 44: Malaysia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 45: Rest of Asia Pacific Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

Table 46: Rest of Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 47: Middle East & Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 48: Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 49: Middle East & Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

Table 50: Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2027

Table 51: GCC Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 52: GCC Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 53: South Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 54: South Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 55: Morocco Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 56: Morocco Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 57: Israel Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 58: Israel Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 59: Tunisia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 60: Tunisia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 61: Egypt Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 62: Egypt Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 63: Turkey Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 64: Turkey Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 65: Rest of Middle East & Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 66: Rest of Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 67: Latin America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 68: Latin America Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 69: Latin America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

Table 70: Latin America Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2027

Table 71: Brazil Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 72: Brazil Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 73: Mexico Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 74: Mexico Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 75: Argentina Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 76: Argentina Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 77: Rest of Latin America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

Table 78: Rest of Latin America Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

Table 79: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Muslim Countries, 2018-2027

Table 80: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Non Muslim Countries, 2018-2027

Table 81: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Non Muslim Countries, 2018-2027

List of Figure

Figure 01: Global Heparin Market Share, by Product (US$ Mn), 2018

Figure 02: Global Heparin Market Share, by Source (% Share), 2018

Figure 03: Market Opportunity Map

Figure 04: Global Heparin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2019–2027

Figure 05: Market Value Share, by Product Type (2018)

Figure 06: Market Value Share, by Formulation (2018)

Figure 07: Market Value Share, by Source (2018)

Figure 08: Market Value Share, by Region (2018)

Figure 09: Global Heparin Market Value Share Analysis, by Product, 2018 and 2027

Figure 10: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth, by Unfractionated Heparin (UFH), 2018–2027

Figure 11: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth, by Low Molecular Weight Heparin (LMWH), 2018–2027

Figure 12: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth, by Ultra-low Molecular Weight Heparin (ULMWH), 2018–2027

Figure 13: Global Heparin Market Attractiveness Analysis, by Product

Figure 14: Global Heparin Market Value Share Analysis, by Source, 2018 and 2027

Figure 15: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bovine, 2018–2027

Figure 16: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porcine, 2018–2027

Figure 17: Global Heparin Market Attractiveness, by Source

Figure 18: Global Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

Figure 19: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral Formulation, 2018–2027

Figure 20: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral Formulation, 2018–2027

Figure 21: Global Heparin Market Attractiveness, by Formulation

Figure 22: Global Heparin Market Value Share Analysis, by Region, 2018 and 2027

Figure 23: Global Heparin Market Attractiveness Analysis, by Region

Figure 24: North America Heparin Market Size (US$ Mn) Forecast, 2019–2027

Figure 25: North America Heparin Market Attractiveness Analysis, by Country

Figure 26: North America Heparin Market Value Share Analysis, by Product, 2018 and 2027

Figure 27: North America Heparin Market Value Share Analysis, by Source, 2018 and 2027

Figure 28: North America Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

Figure 29: North America Heparin Market Attractiveness Analysis, by Product

Figure 30: North America Heparin Market Attractiveness Analysis, by Source

Figure 31: North America Heparin Market Attractiveness Analysis, by Formulation

Figure 32: North America Heparin Market Value Share Analysis, by Country, 2018 and 2027

Figure 33: Europe Heparin Market Size (US$ Mn) Forecast, 2019–2027

Figure 34: Europe Heparin Market Attractiveness Analysis, by Country/Sub-region

Figure 35: Europe Heparin Market Value Share Analysis, by Product, 2018 and 2027

Figure 36: Europe Heparin Market Value Share Analysis, by Source, 2018 and 2027

Figure 37: Middle East & Africa Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

Figure 38: Middle East & Africa Heparin Market Attractiveness Analysis, by Product

Figure 39: Middle East & Africa Heparin Market Attractiveness Analysis, by Source

Figure 40: Middle East & Africa Heparin Market Attractiveness Analysis, by Formulation

Figure 41: Middle East & Africa Heparin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 42: Latin America Heparin Market Size (US$ Mn) Forecast, 2019–2027

Figure 43: Latin America Heparin Market Attractiveness Analysis, by Country

Figure 44: Latin America Heparin Market Value Share Analysis, by Product, 2018 and 2027

Figure 45: Latin America Heparin Market Value Share Analysis, by Source, 2018 and 2027

Figure 46: Latin America Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

Figure 47: Latin America Heparin Market Attractiveness Analysis, by Product

Figure 48: Latin America Heparin Market Attractiveness Analysis, by Source

Figure 49: Latin America Heparin Market Attractiveness Analysis, by Formulation

Figure 50: Latin America Heparin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 51: Global Heparin Market Forecast split, by Muslim Countries and Non Muslim Countries, 2018

Figure 52: Global Heparin Market Share Analysis, by Company, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Heparin Market

Schedule a Call